会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • SELECTION AND EVOLUTION OF NUCLEIC ACIDS AND POLYPEPTIDES
    • 核酸和多糖的选择和演变
    • WO2003044194A1
    • 2003-05-30
    • PCT/US2002/037103
    • 2002-11-18
    • PROTEONOVA, INC.WILLIAMS, Richard, B.
    • WILLIAMS, Richard, B.
    • C12N15/10
    • C12N15/1062
    • This invention relates to methods and reagents for selecting a desired protein or nucleic acid molecule by linking mRNA, with known or unknown sequences, to its translated protein to form a cognate pair. The cognate pair is selected based upon desired properties of the protein or the nucleic acid. This method also includes the evolution of a desired protein or nucleic acid molecule by amplifying the nucleic acid portion of the selected cognate pair, introducing variation into the nucleic acid, translating the nucleic acid, attaching the nucleic acid to its protein to form a second cognate pair, and re-selecting this cognate pair based upon desired properties.
    • 本发明涉及通过将已知或未知序列的mRNA与其翻译的蛋白质连接以形成同源对来选择所需蛋白质或核酸分子的方法和试剂。 基于蛋白质或核酸的所需性质选择同源对。 该方法还包括通过扩增所选择的同源对的核酸部分,引入核酸的变异,翻译核酸,将核酸连接到其蛋白质以形成第二个同源物,从而演化期望的蛋白质或核酸分子 并且基于所需的属性重新选择该同源对。
    • 4. 发明申请
    • METHOD FOR MAKING TARGETED THERAPEUTIC AGENTS
    • 制造针对性治疗剂的方法
    • WO2006076417A1
    • 2006-07-20
    • PCT/US2006/000956
    • 2006-01-12
    • PROTEONOVA, INC.WILLIAMS, Richard, B.
    • WILLIAMS, Richard, B.
    • C07H21/02C07K14/00A61K39/00
    • C07K16/30C07K14/00C07K2319/30G01N33/531G01N33/6845
    • Provided herein are methods and kits for making a targeted therapeutic for treating a disease or condition. The therapeutic agents can be targeted to patient-specific disease markers. In one of these methods, the method includes obtaining a biological sample from a patient having the disease or condition, or who is at risk for developing the disease or condition. In this particular method, the sample includes a population of diseased cells, screening a library comprising proteins linked to their cognate mRNAs to identify mRNA-protein pairs that bind to the diseased cells, isolating one or more proteins from the identified mRNA-protein pairs, and conjugating the isolated protein(s) to a therapeutic agent. Some of the methods further include preparing a library with proteins linked to their cognate mRNAs. In certain of these methods, the preparation of the library includes providing at least two candidate mRNA molecules in which each of the mRNA molecules includes a cross-linker, translating at least two of the candidate mRNA molecules to generate at least one translated protein, and linking at least one of the candidate mRNA molecules to its corresponding translated protein via the cross-linker to form at least one cognate pair.
    • 本文提供了用于制备用于治疗疾病或病症的靶向治疗剂的方法和试剂盒。 治疗剂可以靶向患者特异性疾病标记物。 在这些方法之一中,该方法包括从具有疾病或病症的患者或患有发展疾病或病症风险的患者获得生物样品。 在该特定方法中,样品包括患病细胞群,筛选包含与其同源mRNA相连的蛋白质的文库,以鉴定结合病变细胞的mRNA-蛋白质对,从鉴定的mRNA-蛋白质对分离一种或多种蛋白质, 并将分离的蛋白质与治疗剂缀合。 一些方法还包括用与其同源mRNA相连的蛋白质制备文库。 在这些方法的某些中,文库的制备包括提供至少两个候选mRNA分子,其中每个mRNA分子包括交联剂,翻译候选mRNA分子中的至少两个以产生至少一个翻译的蛋白质,以及 通过交联剂将候选mRNA分子中的至少一种与其相应的翻译蛋白连接以形成至少一个同源对。
    • 5. 发明申请
    • SYSTEM AND METHODS FOR NUCLEIC ACID AND POLYPEPTIDE SELECTION
    • 用于核酸和多肽选择的系统和方法
    • WO2005072087A3
    • 2005-11-03
    • PCT/US2004041380
    • 2004-12-10
    • PROTEONOVA INCWILLIAMS RICHARD B
    • WILLIAMS RICHARD B
    • C07H21/04C12Q1/68
    • C12Q1/6811C12N15/1062
    • This invention relates generally to systems and methods for identifying and selecting, desired proteins or nucleic acid molecules by linking mRNA, with known or unknown sequences, to its translated protein to form a cognate pair. The cognate pair is selected based upon desired properties of the protein or the nucleic acid. This method also includes the evolution of a desired protein or nucleic acid molecule by amplifying the nucleic acid portion of the selected cognate pair, introducing variation into the nucleic acid, translating the nucleic acid, attaching the nucleic acid to its protein to form a second cognate pair, and re-selecting this cognate pair based upon desired properties. Modified mRNAs operable to crosslink to tRNAs are also provided. Methods of producing a psoralen monoadduct or a crosslink are also provided. Methods of producing mRNA libraries and vaccines are also provided.
    • 本发明一般涉及通过将mRNA与已知或未知序列连接到其翻译的蛋白质以形成同源对来鉴定和选择所需蛋白质或核酸分子的系统和方法。 基于蛋白质或核酸的所需性质选择同源对。 该方法还包括通过扩增所选择的同源对的核酸部分,引入核酸的变异,翻译核酸,将核酸连接到其蛋白质以形成第二个同源物,从而演化期望的蛋白质或核酸分子 并且基于所需的属性重新选择该同源对。 还提供了可操作以交联至tRNA的修饰的mRNA。 还提供了补骨脂素单加成物或交联剂的制备方法。 还提供了产生mRNA文库和疫苗的方法。
    • 8. 发明申请
    • SYSTEM AND METHODS FOR NUCLEIC ACID AND POLYPEPTIDE SELECTION
    • 用于核酸和多肽选择的系统和方法
    • WO2005072087A2
    • 2005-08-11
    • PCT/US2004/041380
    • 2004-12-10
    • PROTEONOVA, INC.WILLIAMS, Richard, B.
    • WILLIAMS, Richard, B.
    • C07H21/04C12Q1/68
    • C12Q1/6811C12N15/1062
    • This invention relates generally to systems and methods for identifying and selecting, desired proteins or nucleic acid molecules by linking mRNA, with known or unknown sequences, to its translated protein to form a cognate pair. The cognate pair is selected based upon desired properties of the protein or the nucleic acid. This method also includes the evolution of a desired protein or nucleic acid molecule by amplifying the nucleic acid portion of the selected cognate pair, introducing variation into the nucleic acid, translating the nucleic acid, attaching the nucleic acid to its protein to form a second cognate pair, and re-selecting this cognate pair based upon desired properties. Modified mRNAs operable to crosslink to tRNAs are also provided. Methods of producing a psoralen monoadduct or a crosslink are also provided. Methods of producing mRNA libraries and vaccines are also provided.
    • 本发明一般涉及用于通过将mRNA与已知或未知序列连接至其翻译的蛋白质以形成同源对来鉴定和选择所需蛋白质或核酸分子的系统和方法。 根据蛋白质或核酸的期望特性选择同源对。 该方法还包括通过扩增所选同源对的核酸部分,将变异引入核酸,翻译核酸,将核酸附着到其蛋白质以形成第二同源物,从而产生期望的蛋白质或核酸分子 对,并基于期望的性质重新选择该同源对。 还提供了可操作以交联至tRNA的修饰的mRNA。 还提供了生产补骨脂素单加成物或交联的方法。 还提供了产生mRNA文库和疫苗的方法。